64
Participants
Start Date
May 30, 2017
Primary Completion Date
January 13, 2022
Study Completion Date
November 15, 2023
UPA-ECx1
Evaluating the pharmacodynamic and pharmacokinetic outcomes in obese women using 30mg of UPA-based EC
UPA-ECx2
Evaluating the pharmacodynamic and pharmacokinetic outcomes in obese women using 60mg of UPA-based EC
OHSU, Portland
National Institutes of Health (NIH)
NIH
Oregon Health and Science University
OTHER